Company Filing History:
Years Active: 2019-2024
Title: The Innovative Contributions of Ian D Waddell
Introduction
Ian D Waddell is a notable inventor based in Manchester, GB. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that target specific enzyme activities. With a total of 4 patents to his name, Waddell's work is paving the way for advancements in medical treatments.
Latest Patents
Waddell's latest patents focus on PARG inhibitory compounds. These compounds are designed to inhibit the activity of the enzyme Poly ADP-ribose glycohydrolase (PARG). The invention details compounds of formula I, which are crucial in the treatment of proliferative disorders, including cancer. The patents also encompass processes for the preparation of these compounds and their pharmaceutical applications.
Career Highlights
Ian D Waddell is currently associated with Cancer Research Technology Limited, where he continues to innovate in the field of cancer research. His work is instrumental in developing new therapeutic strategies that could potentially improve patient outcomes.
Collaborations
Waddell collaborates with esteemed colleagues such as Alison E McGonagle and Allan Michael Jordan. These partnerships enhance the research efforts and contribute to the advancement of cancer treatment methodologies.
Conclusion
Ian D Waddell's contributions to the field of biotechnology and cancer research are noteworthy. His innovative work on PARG inhibitory compounds exemplifies the potential of targeted therapies in treating serious health conditions.